Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2008 May;15(5):357–367. doi: 10.1101/lm.902708

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2008, Cold Spring Harbor Laboratory Press

PMC Copyright notice

Figure 4. — Performance with drug injections in the mPFC. (A) Overall performance (location-in-place and object-in-place arms combined) for 4 d with either saline (SAL) or muscimol (MUS) injected in mPFC before testing in both lesion groups. (B) Performance for location-in-place arms for 4 d with SAL or MUS injection. (Inset) Data from the two SAL-injection days were averaged and the same was done for the two MUS-injection days. The graph shows the overall difference between SAL and MUS conditions within each lesion group. Y-axis, percent correct; LES, HP-LES group; CTRL, HP-CTRL group. (C) Performance for object-in-place arms only for 4 d with SAL or MUS injection. (Inset) Data were averaged as in B for each lesion group. HP-CTRL, control lesion group; HP-LES, neurotoxic lesion group. All graphs show mean ± SEM.